NEW ZEALAND GAZETTE

No. 1

of Food Technologists, Generally Recognised As Safe (GRAS) lists of flavouring substances published by the Flavor and Extract Manufacturers’ Association of the United States from 1960 to October 1996;

(b) Flavouring Substances and Natural Sources of Flavourings, Fourth Edition, Volume 1, chemically-defined flavouring substances, Council of Europe, 1992;

(c) United States Code of Federal Regulations, 1996, 21 CFR Part 172.515.

Editorial Note: Not all substances listed in the 3 publications referred to in subclause (3A) are artificial flavouring substances. The approval in subclause (3A) relates only to those listed substances which are artificial flavouring substances. The Flavour and Fragrance Association of Australia and New Zealand (FFAANZ) has prepared a list of the artificial flavouring substances in the 3 publications for ease of reference. This list is available from FFAANZ or from the Australia New Zealand Food Authority.

(3B) An artificial flavouring must not contain an artificial flavouring substance unless that substance is a permitted artificial flavouring substance.

(3C) An artificial flavouring may contain one or more of the following:

(a) a natural flavour concentrate;

(b) a natural flavouring substance;

(c) a nature-identical flavouring substance; or

(d) a natural aromatic raw material.";

[4.2] omitting subparagraph 2 (4) (a) (xviii); and

[4.3] omitting the Schedule.

5. Standard A8 is varied by—

[5.1] inserting "partially hydrogenated cottonseed oil" after "mono-, di- and polysaccharides" in subclause (3) (b);

[5.2] omitting "microcrystalline cellulose" from subclause (3) (c);

[5.3] inserting after subparagraph (3) (e) (ia)—

"(ib) alitame;";

[5.4] omitting "not permitted" from the Table to clause (5) in the column headed "Alitame" in relation to the entry for "Chewing Gum" and substituting "150 mg/kg"; and

[5.5] omitting "not permitted" from the Table to clause (5) in the column headed "Alitame" in relation to the entry for "Electrolyte drink and electrolyte drink base" and substituting "20 mg/kg".

6. Standard A9 is varied by—

[6.1] omitting from the Table to clause 3, the entry in column 5 relating to the maximum permitted level of zinc in textured vegetable protein; and

[6.2] inserting "zinc oxide" in column 2 of the Schedule in relation to the entry for "Zinc" in column 1.

7. Standard A10 is varied by inserting "Microcrystalline cellulose," after "Methylcellulose," in Table 1, Group I—Vegetable Gums.

8. Standard A11 is varied by—

[8.1] omitting paragraph (1) (s);

[8.2] omitting "Addendum 2" from column 2 of the Schedule in relation to the entry in column 1 for "Alitame" and substituting "FNP (52/4) p3";

[8.3] omitting "FCC p79" from column 2 of the Schedule in relation to the entry in column 1 for "Cellulose, microcrystalline" and substituting "FCC IV p95";

[8.4] omitting "FNP (34) p129" from column 2 of the Schedule in relation to the entry in column 1 for "Isomalt" and substituting "FNP (52/4) p79";

[8.5] inserting in the Schedule, into columns 1 and 2 respectively—

"Erythrosine (CI 45430) FNP (31/1) p71";

[8.6] omitting "FCC p24" from column 2 of the Schedule in relation to the entry in column 1 for "Potassium chloride" and substituting "FCC IV p315";

[8.7] inserting in columns 1 and 2 of the Schedule respectively:

"Zinc oxide FCC p350"; and

[8.8] omitting Addendum 2.

9. Standard A12 is varied by—

[9.1] inserting ", ling," after both occurrences of "barramundi", in column 2 of the Table to clause (2), in relation to the entry in column 1 for "Mercury"; and

[9.2] inserting ", ling," after each occurrence of "barramundi", in clause (7).

10. Standard A14 is varied by—

[10.1] inserting after subclause 4 (4)—

"(5) A residue of a chemical listed in column 1 of Schedule 1 is to be determined as follows:

[10.2] omitting all foods specified in column 1 and all MRLs specified in column 2 from Schedule 1 in relation to the chemicals—

(a) Mancozeb

(b) Metham

(c) Metiram

(d) Propineb

(e) Thiram

(f) Ziram;

[10.3] inserting ", see Dithiocarbamates" after "Propineb" in column 1 of Schedule 1;

[10.4] omitting entries in columns 1 and 2 respectively